caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1639431646

Marisa HowellMD

Internal MedicineJonesboro, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Marisa Howell's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE PROVIDENCE COMMUNITY HEALTH CENTERS, INC.97480
WOMEN & INFANTS HOSPITAL OF RHODE ISLAND2139
THE MIRIAM HOSPITAL1330
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
12
Unique beneficiaries
—
Total services
17
Distinct HCPCS
1
Medicare payment
$2K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,751 Internal Medicine providers in GA — bottom quintile (cohort median 670).
PRESCRIBING · PART D · 2024
Total Rx claims
6,657
Beneficiaries
—
Total drug cost
$236K
Distinct drugs
102
Brand share
23.3%
Top prescribed drugs
Amlodipine Besylate460 claims
Atorvastatin Calcium447 claims
Rosuvastatin Calcium276 claims
Losartan Potassium257 claims
Gabapentin210 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.